These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39043809)

  • 21. Association of HMGCR inhibition with rheumatoid arthritis: a Mendelian randomization and colocalization study.
    Ma L; Du Y; Ma C; Liu M
    Front Endocrinol (Lausanne); 2023; 14():1272167. PubMed ID: 38047111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Lipid-Lowering Drugs With Risk of Psoriasis: A Mendelian Randomization Study.
    Zhao SS; Yiu ZZN; Barton A; Bowes J
    JAMA Dermatol; 2023 Mar; 159(3):275-280. PubMed ID: 36696131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of lipid-lowering drug targets with risk of cutaneous melanoma: a mendelian randomization study.
    Miao L; Miao T; Zhang Y; Hao J
    BMC Cancer; 2024 May; 24(1):602. PubMed ID: 38760735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential associations of statin treatment and polymorphism in genes coding for HMGCR and PCSK9 to risk for insomnia.
    Alsehli AM; Rukh G; Clemensson LE; Ciuculete DM; Tan X; Al-Sabri MH; Williams MJ; Benedict C; Schiöth HB
    Front Biosci (Landmark Ed); 2021 Dec; 26(12):1453-1463. PubMed ID: 34994160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study.
    Dib MJ; Zagkos L; Meena D; Burgess S; Chirinos JA; Gill D
    Stroke; 2024 Jun; 55(6):1676-1679. PubMed ID: 38572634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between diabetic retinopathy and diabetic nephropathy: a two-sample Mendelian randomization study.
    Fang J; Luo C; Zhang D; He Q; Liu L
    Front Endocrinol (Lausanne); 2023; 14():1265711. PubMed ID: 38027162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetically proxied low-density lipoprotein cholesterol lowering via PCSK9-inhibitor drug targets and risk of congenital malformations.
    Ardissino M; Slob EAW; Reddy RK; Morley AP; Schuermans A; Hill P; Williamson C; Honigberg MC; de Marvao A; Ng FS
    Eur J Prev Cardiol; 2024 Jun; 31(8):955-965. PubMed ID: 38294056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study.
    Yan Z; Xu Y; Li K; Liu L
    Medicine (Baltimore); 2023 Sep; 102(39):e34690. PubMed ID: 37773823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function.
    Rosoff DB; Bell AS; Jung J; Wagner J; Mavromatis LA; Lohoff FW
    J Am Coll Cardiol; 2022 Aug; 80(7):653-662. PubMed ID: 35953131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically instrumented LDL-cholesterol lowering and multiple disease outcomes: A Mendelian randomization phenome-wide association study in the UK Biobank.
    Pham K; Mulugeta A; Lumsden A; Hyppӧnen E
    Br J Clin Pharmacol; 2023 Oct; 89(10):2992-3004. PubMed ID: 37208559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations of genetically determined lipid traits and lipid-modifying agents with the risk of diabetic retinopathy: A Mendelian randomization study.
    Li N; Zhang X; Zhang M; Wu L; Li C; Pan Y; Wang W; Ji J; Zheng D
    Atherosclerosis; 2023 Mar; 369():9-16. PubMed ID: 36827905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ACLY Inhibition on Body Weight Distribution: A Drug Target Mendelian Randomization Study.
    Gill D; Dib MJ; Gill R; Bornstein SR; Burgess S; Birkenfeld AL
    Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202419
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study.
    Rosoff DB; Bell AS; Mavromatis LA; Hamandi A; Park L; Jung J; Wagner J; Pacher P; Ray D; Davey Smith G; Lohoff FW
    Circ Genom Precis Med; 2024 Feb; 17(1):e004224. PubMed ID: 38258565
    [No Abstract]   [Full Text] [Related]  

  • 34. Causal association between lipid-lowering drugs and female reproductive endocrine diseases: a drug-targeted Mendelian randomization study.
    Zhao J; Wang R; Song L; Han H; Wang P; Zhao Y; Zhang Y; Zhang H
    Front Endocrinol (Lausanne); 2023; 14():1295412. PubMed ID: 38027179
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low LDL cholesterol,
    Benn M; Nordestgaard BG; Frikke-Schmidt R; Tybjærg-Hansen A
    BMJ; 2017 Apr; 357():j1648. PubMed ID: 28438747
    [No Abstract]   [Full Text] [Related]  

  • 36. Sex and statin-related genetic associations at the PCSK9 gene locus: results of genome-wide association meta-analysis.
    Pott J; Kheirkhah A; Gadin JR; Kleber ME; Delgado GE; Kirsten H; Forer L; Hauck SM; Burkhardt R; Scharnagl H; Loeffler M; März W; Thiery J; Gieger C; Peters A; Silveira A; Hooft FV; Kronenberg F; Scholz M
    Biol Sex Differ; 2024 Mar; 15(1):26. PubMed ID: 38532495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study.
    Alghamdi J; Matou-Nasri S; Alghamdi F; Alghamdi S; Alfadhel M; Padmanabhan S
    Int J Neuropsychopharmacol; 2018 Dec; 21(12):1067-1075. PubMed ID: 29986042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study.
    Huang A; Wu X; Lin J; Wei C; Xu W
    Front Endocrinol (Lausanne); 2024; 15():1331031. PubMed ID: 38425755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of lipid-lowering drugs with COVID-19 outcomes from a Mendelian randomization study.
    Huang W; Xiao J; Ji J; Chen L
    Elife; 2021 Dec; 10():. PubMed ID: 34866576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing the Relationships of Genetically Proxied PCSK9 Inhibition With Mood Disorders, Cognition, and Dementia Between Men and Women: A Drug-Target Mendelian Randomization Study.
    Bell AS; Rosoff DB; Mavromatis LA; Jung J; Wagner J; Lohoff FW
    J Am Heart Assoc; 2022 Nov; 11(21):e026122. PubMed ID: 36285785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.